Glaukos

Glaukos Corporation is a glaucoma treatment company based in Laguna Hills, California. Thomas Burns is Glaukos president and CEO.

Products

Glaukos developed the iStent titanium micro-stent. The device, which is AbOUT the width of a human hair, is implanted during cataract surgery to reduce intraocular pressure.

History

Founded in 2001 by Olav Bergheim, Richard Hill and Mory Gharib, the company has raised $126 million in venture funding from Versant Ventures, OrbiMed Advisors, Frazier Healthcare Ventures, InterWest Partners, Meritech Capital Partners, Domain Associates, Fjord Capital Management and Montreux Equity Partners.

The company ranked 19th on the Wall Street Journal's annual Next Big Thing list in 2011.

Glaukos president and CEO Thomas Burns says Glaukos is the first to develop Glaucoma micro-stents and is well ahead of its competitors.

The company ranked seventh on the Wall Street Journal's annual Next Big Thing list in 2012.

In June 2012, the Food and [...] Administration approved the first iStent implant.